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1 Abbreviations used in this paper PC, Pneumocystis carinii; PCP, PC
pneumonia; TBLN, tracheobronchial lymph node.
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Summary
The importance of CD4+ cells in resistance to Pneumocystis carinii (PC) in PC-susceptible severe
combined immunodeficient (SCID) mice that were made resistant to PC by immunocompetent
spleen cell transfer, and in conventional PC-resistant mice, was investigated. SCID mice with
naturally acquired PC pneumonia (PCP) were given infusions of spleen cells from immunocompetent
donors. This reconstitution caused the recipients to resolve their PCP. Treatment of reconstituted
SCID mice with anti-CD4 monoclonal antibodies (mAbs) to deplete them of CD4+ cells elim-
inated their ability to resolve PCP, whereas treating them with anti-CD8 mAb to deplete CD8+
cells had no effect. The findings indicate, therefore, that resistance to PCP in immunologically
reconstituted SCID mice is dependent on CD4+ cells. To determine whether CD4+ cells enable
conventional mice to resist PCP, B6D2 mice were treated with anti-CD4 mAb to deplete them
of CD4+ cells in an attempt to induce PCP After 10-11 wk of treatment, these mice developed
progressive PCP Taken together, these results indicate that loss of CD4+ cells predisposes mice
to PC infection.
hereas Pneumocystis carinii (PC)' pneumonia (PCP)
rarely occurs in immunocompetent individuals, it is
a major cause of morbidity and mortality in patients with
AIDS (1). However, the basis ofsusceptibility ofimmunocom-
promised individuals to PCP is not understood. It seems to
be generally believed that susceptibility is a consequence of
the loss of CD4+ T cells, and AIDS is characterized by a
progressive decline in the number and function of CD4+
T cells (2). Moreover the onset ofPCP in AIDS patients gener-
ally does not occur until after numbers ofcirculating CD4+
T cells have declined to <200 cells/mm' of blood (3). How-
ever, this evidence for the need for CD4+ T cells in resis-
tance to PCP is equivocal at best because HIV infection may
compromise the function ofother cells of the immune system,
including macrophages (4, 5). Indeed, it has been suggested
that dysfunction of macrophages is a primary cause of sus-
ceptibility of AIDS patients to opportunistic infections (4).
Attempts to determine the basis of susceptibility to PCP
in animals have involved the use of chronic treatment with
corticosteroids. However, because these compounds have such
broad immunosuppressive effects, the results obtained with
them have not allowed conclusions to be drawn about the
role of a particular cell type in anti-PC resistance. Several
studies, however, have been published that did not utilize
cortisone-treated animals. Furuta et al. (6) found that the
transfer of T cells to PC-infected nude mice enhanced resis-
tance of the recipients to PCP. Another studyjust recently
published`(7) shows that conventional mice chronically
depleted of CD4+ cells become susceptible to PCP. These
studies then . suggest that T cells, and more specifically
CD4+ T cells, play a role in resistance to PCP. To further
investigate the role of CD4+ cells in resistance to PCP and
to determine whether a CD4+ cell-deficient host can be
made resistant to PCP by the transfer of CD4+ cells, we ini-
tiated studies in mice with SCID. This paper will show that
SCID mice given infusions of spleen cells from immunocompe-
tent mice enables the SCID mice to resolve preexisting PCP,
and that depleting these reconstituted SCID mice of CD4+
T cells by treatment with anti-CD4 mAb eliminated their
acquired ability to resolve PCP. This evidence in favor of an
essential role for CD4+ T cells in resistance to PCP is fur-
ther supported by findings of Shellito et al. (7), as well as
our own results shown here that conventional mice chroni-
cally depleted of CD4+ T cells by treatment with anti-CD4
mAb become susceptible to PCP.
Materials and Methods
Mice.
￿
Female BALB/c and B6D2 mice, 8-10 wk of age, were
obtained from the Trudeau Animal Breeding Facility. Foundation
stocks ofC.B-17/Icrscid1scid (SCID) mice, an Igh congenic partner
strain of BALB/c AnIcr (8), were the gift ofDr. Leonard Schultz
ofThe Jackson Laboratory, Bar Harbor, ME. SCID mice were reared
and maintained at the Trudeau Institute under barrier-sustained
conditions and were shown to be free of most common pathogens,
according to tests periodically performed by the diagnostic testing
services of Charles River Professional Services, Wilmington, MA.
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Age of SCID mice in weeks
Figure 1.
￿
Numbers of PC nuclei in the lungs of SCID mice at
different ages. Points are means ± 1 SD ; n = 4 animals. The limit
of detectability was 103 PC nuclei per animal .
B6D2 mice were maintained in open-topped cages in a standard
animal room and were given food and acidified water ad libitum .
Antibodies and FACS Analysis. ThehybridomaGK1.5 (Dr . Frank
Fitch, University ofChicago, Chicago, IL) secreting rat IgG2b anti-
CD4 mAb, hybridoma TIB-210 (American Type Culture Collec-
tion, Rockville, MD) producing rat IgG2b anti-CD8, and hy-
bridomaHB92 (AmericanType Culture Collection) producing rat
IgG2b anti-,y chain were grown as ascites in pristane-primed, ir-
radiated BALB/c mice . TheIgG2b content of the ascites fluid was
quantified by radial immunodiffusion, and the fluids were stored
at -70°C until needed . Some oftheSCID miceinfused with spleen
cells (hereafter referred to as reconstituted mice) received intrave-
nous injections of 0.5 mg anti-CD4 or anti-CD8 1, 6, and 12 d
after injection of spleen cells. The extent ofT cell depletion was
determined by cytofluorometric analysis with aFACScan cytofluo-
rometer (Becton Dickinson & Co ., Mountain View, CA) . Spleen
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cells, tracheobronchial lymph node (TBLN) cells, andlung lavage
cells were stained with FITC-conjugated anti-CD4, anti-CD8
(9), anti-mouse Ig, and anti-rat Ig (Cappel Laboratories, West-
chester, PA) .
Enumeration ofPC in the Lungs of Mice.
￿
The number of PC
nuclei in the lungs of mice was determined as described elsewhere
(10), butwith some modifications . Mice were anesthetized, exsan-
guinated, and their lungs excised . The lungswere pushed through
a stainless steel screen into 5 ml of PBS, diluted 1:20, and 0.1 ml
of the resulting suspension was fixed onto a 28.3-mm2 area of a
glass slide by the use of a cytocentrifuge (Shandon, Sewickly, PA),
and stained with DiffQuik . Thenumber ofPC nuclei per 20-100
oil emersion fields was determined, converted into total nuclei in
0.1 of lung homogenate, and used to calculate total PC nuclei per
lungs . With this method, one nuclei counted in 100 fields equates
to slightly more than 103 PC nuclei per lung. Therefore, 103 nuclei
per lung was considered the limit of detectability. Themean per-
cent variance among counts done by individual investigators in this
lab when counting the same PC preparation is 11% . All counts
done within an experiment were done by a single investigator
reading the slides in a random, blinded manner.
Some lungs were fixedby intravenous perfusion ofbuffered for-
malin, processed, embedded in paraffin, and sectioned . Sections were
stained with hematoxylin + eosin or with Gomori-Grocott silver
stain (11) .
Spleen Cell Transfers and In Vitro Depletion of CD4* or CD8
CZ Spleens were collected from BALB/c mice, diced into small
pieces, gently pushed through stainless steel screens into PBS con-
taining 1% FCS, repeatedly passed through a Pasteur pipette to
reduce cell clumps, and filtered through sterile gauze to remove
debris. The cells were then washed twice in PBS, counted, and
resuspended at 108 nucleated cells per ml of PBS . SCID mice were
given 1 ml of the spleen cell suspension intravenously. Some of
these reconstituted mice then received injections of 0.5 mg anti-
CD4or anti-CD8 at 1, 6, and 12 d after reconstitution . At different
times after reconstitution, the numbersof PC in the lungs of the
reconstituted and unreconstituted SCID mice were determined.
Figure 2.
￿
Photomicrograph of Gomori-
Grocott silver-stained section of SCID
mouse lung . Note darkly stained PC cysts
lining the alveoli (x400) .Table 1.
￿
Numbers of PC Nuclei in Lung Homogenates of
SCID Mice 19-27 d after Reconstitution with Immunocompetent
Spleen Cells and Depletion of T Cells
Treatment
Controls (19-27 d)
Spleen cell-reconstituted (19 d)
Spleen cell-reconstituted (27 d)
￿
<3.0 (7)S
Results
No. of PC nuclei
10910
7.2 ± 0.1 (12)"
3.7 ± 0.8 (12)1
i Numbers represent means ± 1 SEM (numbers of mice compiled
from two to four experiments).
t Significantly lower than control (p < 0.01).
5 Less than detectable number.
II Significantly greater than control (p < 0.01).
I Significantly lower than control (p < 0.05).
The lungs of some of the mice were lavaged as previouslydescribed
(12). At the same time, the spleens and tracheobronchial lymph
nodes were excised, single cell suspensions prepared, and the numbers
of CD4', CD8', and Ig' cells in the suspensions and lung la-
vage fluids determined by cytofluorometric analysis.
Depletion ofCD4' Cells by Infusion ofAnti-CD4 mAb into Con-
ventional B6D2 Mice. To test directly whether CD4' cells are re-
quired for resistance to PCP, an attempt was made to induce PCP
in conventional B6D2 mice by depleting them of CD4' T cells.
Groups of normal and thymectomized B6D2 mice were given 0.5
mg anti-CD4 mAb (GK1.5 ascites) twice a week for 8 wk and
once a week thereafter. The mice were maintained understandard
husbandry conditions in open-topped cages in a conventional an-
imal room. Mice were killed at progressive times, and PC nuclei
in their lungs were enumerated. In addition, C134', CD8', and
Ig+ cell numbers in the spleens, TBLN, and lung lavage fluids of
some of the mice were determined as described above.
Statistics.
￿
The significance ofdifferences in means ofPC numbers
in the lungs of groups of mice was calculated utilizing the stu-
dent's t test.
Colonization ofPC in the Lungs ofSCID Mice.
￿
Groups
of four SCID mice each were killed at 3, 5, 7, 9, and 11 wk
of age, and the numbers of PC nuclei in their lungs were
determined. As shown in Fig. 1, PC nuclei were not detect-
able in the lungs of 3-wk-old SCID mice, but "105-3 nuclei
were found in the lungs of 5-wk-old SCID mice. The numbers
of PC then gradually increased with time and reached "101-1
at 11 wk of age. Thus, PC increased in numbers -10-fold
in SCID mice when determined ti7 and -11 wk of age. Mice
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used in the following experiments were N7 wk of age at
the start of the respective experiment.
Histological examination of hematoxylin- and egsin-stained
sections of the lungs of SCID mice (results not shown), at
7-11 wk of age, revealed essentially normal lung architec-
ture, and the presence ofPC was not readily apparent. How-
ever, examination of silver-stained sections of thg lungs of
these mice did confirm the presence ofPC cysts (F g. 2). The
SCID mice of 11 wk of age and less had a normal, healthy
appearance, but by 15 wk of age, the mice appe ed to have
lost weight and had respiratory difficulties. Theses mice usu-
ally contained -10a PC in their lungs (results not shown),
and histological examination revealed that many of,theirlung
alveoli were filled with an eosinophilic exudate composed of
clumps of PC trophozoites and cysts. These lungs appeared
to have the same histological appearance as has een previ-
ously described in SCID mice with heavy PC burdens (13).
Resolution ofPCPbyReconstitutedSCIDMice
￿
Tlenumbers
ofPC nuclei in lung homogenates ofSCID mice after recon-
stitution with immunocompetent spleen cells areshown in
Table 1. SCID mice not reconstituted with spleen cells had
ti107.2 PC nuclei in the homogenates of their lungs, whereas
reconstitution of SCID mice reduced their lung PC burden
to 103.7 nuclei (p < 0.01) at 19 d and to <103-1 (less than a
detectable number) nuclei at 27 d after reconstitution. Treat-
ment of reconstituted SCID mice with anti-CD8 '~Ab had
no effect on the ability of the recipients to clear PC from
theirlungs. In contrast, treatment with anti-CD4 eliminated
the ability of reconstituted SCID mice to resolve their PCP.
Examination of sections of reconstituted SCID mice to re-
solve theirPCP Examination of sections ofparaffin-embedded
tissue stained with Gomori-Grocott silver confirmed that
reconstitution of SCID mice caused clearance of PC cystsfrom
the lungs (Figs. 2 and 3).
The numbers of CD4', CD8', and Ig' cells in spleens
and TBLN of mAb-treated SCID mice at 19 d after'reconsti-
tution are shown in Tables 2 and 3, respectively. These results
are of one of three experiments performed but represent similar
results found in all three experiments. SCID mice that were
not reconstituted (controls) had few CD4', CD8'', or Ig'
cellsin their spleens. In fact, the number of stained cellswere
similar to the numbers of cells that-stained with anti-rat Ig
(results not shown) . No values for cell numbers in the TBLN
of control mice are given since the TBLN of these mice were
too small to be located. CD4', CD8', and Ig' cells were
detected in both spleen and TBLN suspensions of SC:ID mice
reconstituted with immunocompetent spleen cells. Recon-
stituted SCID mice that received injections ofanti-Ct)4 mAb
had CD8' and Ig' cells but only very few CD4" cells in
both theirspleen and TBLN suspensions. Reconstituted SCID
mice that received injections of anti-CD8 mAb had CD4'
and Ig' cells but only a few CD8' cells in both their spleen
and TBLN suspensions. These results show that injections
of immunocompetent spleen cells into SCID mice at least
partially reconstitute theirlymphoid tissue. In addition, treat-
ment of the reconstituted SCID mice with anti-CD4 mAb
eliminated CD4' cells, and treatment with anti-CD8 mAb
eliminated CD8' cells.
Spleen cell-reconstituted + anti-CD4
mAb (19 d) 7.7±0.1(8)11
Spleen cell-reconstituted + anti-CD4
mAb (21-27 (1) 8 .2±0.1(4)11
Spleen cell-reconstituted + anti-CD8
mAb (19 d) 3 .9 ± 1.9 (3)1Cells in the lung lavage fluids of unreconstituted SCID
mice contained predominantly macrophages with very few
neutrophils and lymphocytes (Fig. 4) . However, the lung la-
vage fluids ofSCID mice at 19 d after reconstitution con-
tained large numbers of lymphoblasts, lymphocytes, neutro-
phils, enlarged macrophages, and giant cells (Fig . 5) . The
numbers andtype ofleukocytes in lung lavage fluids ofrecon-
stituted and anti-CD4- or anti-CD8-treated SCID mice were
Table 2.
￿
Numbers of CD4', CD8', and Ig' Cells in
Spleens o,fmAb-treated SCID Mice 19-27 d after Reconstitution
with Immunocompetent Spleen Cells
" Numbers are means of measurements from two or three spleens .
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Figure 3.
￿
Photomicrograph of Gomori-
Grocott silver-stained section of SCID
mouse lung at 19 d after reconstitution
with immunocompetent spleen cells. Note
absence of darkly stained PC cysts (x400) .
similar to that observed for reconstituted SCID mice not
treated withmAb. However, thelung lavage fluids ofrecon-
stituted and anti-CD4 mAb-treated SCID mice also contained
large numbers of RBC (Fig . 6) . The presence of the RBC
in these mice could indicate severe pulmonary damage, and
indeed, these mice appeared to be very ill before they were
Table 3.
￿
Numbers of CD4 +, CD8 +, and Ig' Cells in
TBLN o,fmAb-treated SCID Mice 19-27 d after Reconstitution
with Immunocompetent Spleen Cells
No . of cells per TBLN
Treatment
Controls (19-27 d)
Spleen cell-reconstituted (19 d)
Spleen cell-reconstituted (27 d)
Spleen cell-reconstituted +
anti-CD4 mAb (19 d)
Spleen cell-reconstituted +
anti-CD4 mAb (21-27 d)
Spleen cell-reconstituted +
anti-CD8 mAb (19 d)
' TBLN were not visible in SCID mice that had not been recon-
stituted with spleen cells so that the presence of T cells could not
be determined .
t Numbers are means of two separate pools of cells from TBLN .
CD4+
ND'
CD8'
x 106
ND
Ig +
ND
2.25# 0.63 1 .78
1.33 1.28 4 .27
0.02 3.15 1 .20
0.01 3.40 2.40
0.88 0.02 1 .48
Treatment
No . of
CD4'
cells per
CD8'
spleen
Ig'
x 10 6
Controls (19-27 d) 0.18' 0.03 0.03
Spleen cell-reconstituted (19 d) 2.50 0.29 3 .08
Spleen cell-reconstituted (27 d) 1.26 1.35 7 .78
Spleen cell-reconstituted + anti-CD4
mAb (19 d) 0 .02 0.30 1 .10
Spleen cell-reconstituted + anti-CD4
mAb (21-27 d) 0 .02 1.21 4.60
Spleen cell-reconstituted + anti-CD8
mAb (19 d) 1 .10 0.02 0.86killed . At 27 d after reconstitution, the cells in the lung la-
vage fluids ofSCID mice were similar in numbers and types
to those of unreconstituted SCID mice, except that a few
lymphocytes were present and many more of the macrophages
had indented nuclei and lightly stained cytoplasm (Fig . 7) .
These macrophages were similar in appearance to blood
monocytes.
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Figure 4.
￿
Lung lavage cells from a con-
trol SCID mouse. Note that cells are pre-
dominantly macrophages. Cytocentrifuge
preparation was stained with DiffQuik
(x400) .
Cytofluorometric analysis of lung lavage fluid cellsshowed
that at 19 d after reconstitution, SCID mice had large numbers
ofCD4+ cells in their lungs and relatively few CD8+ cells
(Table 4, representative results of one of three experiments
performed) . Reconstituted SCID mice treated with anti-CD8
mAb also contained large numbers of CD4+ cells in their
lungs and few CD8+ cells, whereas anti-CD4 mAb-treated
Figure 5 .
￿
Lung lavage cells from a
SCID mouse 19 d after reconstitution
with spleen cells. Note the presence of
numerous lymphocytes, neutrophils, and
enlarged basophilic macrophages . The
arrow points to a macrophage containing
a PC cyst . Cytocentrifuge preparation
was stained with DiffQuik (x400) .recipients contained large numbers of CD8+ cells but few
CD4+ cells. At 27 d after reconstitution, the numbers of
CD4+ cells and CD8+ cells in lung lavage fluids of recon-
stituted SCID mice had decreased to values similar to those
of untreated SCID mice .
Cellular Responses in theLungs ofPC-free SCID Mice Given
an Infusion ofSpleen Cells. The infusion of BALB/c spleen
cells into SCID mice could possibly result in a cellular re-
sponse in the lungs of the recipients that is not driven by
942 CD4+ Cells Are Required for Resistance to Pneumocystis
Figure 6 .
￿
Lung lavage cells from a
SCID mouse 19 d after spleen cell recon-
stitution and CD4+ cell depletion . The
cell populations present are similar to
those in Fig . 2, except that numerous
erythrocytes are also present . The arrow
points to a clump of PC . Cytocentrifuge
preparation was stained with Dig-Quik
(x400) .
the presence ofPC . One way to test this possibility would
be to examine the cellular response in the lungs of PC-free
SCID mice after the mice were given injections of BALB/c
spleen cells . PCP-free SCID mice were produced by mating
spleen cell-reconstituted male and female SCID that had
resolved theirPCP. The offspring ofthe reconstituted SCID
wereshown to remain free ofPCP for 14wk when kept under
barrier conditions (results not shown) . These PCP-free mice
and PC-infected control SCID mice were then given an infu-
Figure 7 .
￿
Lung lavage cells from a SCID
mouse 27 d after reconstitution with spleen
cells. Note that the cells are predominantly
macrophages with few lymphocytes pre-
sent . Many of the macrophages contain in-
dented nuclei and have the appearance of
blood monocytes. Cytocentrifuge prepara-
tion was stained with Dig--Quik (x400).Table 4.
￿
Numbers of CD4+, CD8+, and Ig+ Cells in Lung
Lavage Fluids of mAb-treated SCID Mice 19-27 d after Reconsti-
tution with Immunocompetent Spleen Cells
Treatment
Controls (19-27 d)
Spleen cell-reconstituted (19 d)
Spleen cell-reconstituted (27 d)
Spleen cell-reconstituted +
anti-CD4 mAb (19 d)
Spleen cell-reconstituted +
anti-CD4 mAb (21-27 d)
Spleen cell-reconstituted +
anti-CD8 mAb (19 d)
" Numbers represent means of measurements of two to three lung
lavage samples.
t <0.01 is less than detectable numbers.
sion of 108 BALB/c spleen cells. After 15 d, the mice were
killed, and the numbers of CD4+, CD8+, and Ig+ cells in
their spleens and lung lavage fluids were determined. The
results (Table 5) show that reconstituted PC-free SCID mice
had few lymphocytes accumulatein theirlungs, whereas large
numbers of both CD4+ and CD8+ cells accumulated in the
lungs of PC-infected SCID mice.
Development ofPCP in B6D2 Mice Depleted ofCD4+ Cells
by Treatmentwith Anti-CD4 mAls As shown in Table 6, mice
treated with anti-CD4 mAb did not contain detectable
numbers of PC nuclei in their lungs at day 50 of treatment.
However, mice that were treated for 81 or 95 d contained
1064 and 1066 PC nuclei, respectively, in their lungs. Again,
thymectomized mice treated with anti-CD4 mAb had 105.5
Table 5.
￿
Numbers of CD4+, CD8', and Ig+ Cells in Lung
' Numbers represent means of measurements of four mice.
t < 0.01 is less than detectable numbers.
943
￿
Harmsen and Stankiewicz
Table 6.
￿
Numbers of PC Nuclei in Lung Homogenates of
B6D2 Mice after 50-95 d of Treatment with anti-CD4 mAb
and 107.2 PC nuclei in their lungs at 71 and 85 d of treat-
ment. No PC were detected in the lungs ofeither age-matched
controls or B6D2 mice treated with control mAb.
Results of cytofluorometric analysis of lymphocytes from
the spleens, TBLN, and lung lavage fluids of anti-C134-treated
B6D2 mice are shown in Table 7. As was expected, thymec-
tomized, anti-CD4 mAb-treated mice had very few CD4+
cells in their spleens and TBLN compared with untreated
B6D2 mice. However, treatment with anti-CD4 mAb had
little effect on CD8+ and Ig+ cell numbers in the spleens
and TBLN of treated mice. The lung lavage fluids of both
the anti-CD4 mAb-treated mice and control mice contained
Table 7.
￿
Numbers of CD4+, CD8+, and Ig' Cells in
Spleens, TBLN, and Lung Lavage Fluids of Control B6D2
Mice and B6D2 Mice that Had Been Thymectomized and
Treated with anti-CD4 mAb
" Numbers are means of three mice.
No. of cells
No. of
CD4+
cells per lung
CD8+
lavage
Ig+
Exp. Treatment and period
No. of
P. carinii
nuclei
10910
x 106 A Anti-CD4 mAb (50 d) <3.0 (3)'t
<0.01' <0.01 <0.01 Anti-CD4 mAb (81 d) 6.4 t 0.5 (3)
1.93 0.17 0.09 Anti-CD4 mAb (95 d) 6.6 t 0.3 (3)
0.02 0.01 <0.01 Thymectomy + anti-CD4 mAb (71 d) 5.5 ± 0.4 (3)
Thymectomy + anti-CD4 mAb (85 d) 7.2 ± 0.2 (3)
Controls (95-d age-matched) <3.0 (3)
<0.01t 1.95 0.03
B Anti-CD4 mAb (98 d) 6.7 ± 0.4 (7)
0.03 1.70 0.03 Anti--y mAb (98 d) <3.0 (5)
0.89 0.05 0.21
Mean t SD (number of mice).
t Below detectable number.
Lavage Fluids ofPC-infected and PC-free SCID Mice at 15 d Organ Treatment CD4+ CD8+ Ig+
after Reconstitution with Immunocompetent Spleen Cells
x 106
No. of cells per lavage Treated 0.04" 4.8 39 Spleen
SCIDs CD4+ CD8+ Ig+ Control 17.0 7.8 46
TBLN
Treated <0.01 1.0 3.5
x 106 Control 1.7 1.6 0.9
PC-infected 0.7 t 0.1' 0.4 ± 0.1 0.05 ± 0.01
PC-free 0.01t 0.01 0.01 Lung lavage fluid Treated 0.01 2.0 0.05
Control <0 .01 <0.01 <0.01only few CD4+ or Ig+ cells. However, large numbers of
CD8+ cells were detected in the lung lavage fluids of the
treated mice, whereas very few were found in the fluids of
the control mice.
Discussion
Results described in this paper show that SCID mice that
have acquired PC infection from their environment resolve
preexisting PCP after they are given spleen cells from im-
munocompetent donors. This is in agreement with results
reported by Furuta et al. (6), who showed that infusion of
immunocompetent splenic T cells into nude mice with PCP
caused the recipients to clear much of their PC burden. We
also found that CD4+ cells are necessary for reconstituted
SCID mice to resolve their PCP. This conclusion is based
on the finding that treatment of reconstituted SCID mice
with anti-CD4 mAb eliminated the ability of recipients to
resolve PCP, whereas treatment with anti-CD8 mAb had no
effect. Although this finding indicates that susceptibility of
SCID mice to PCP can be reversed by giving them im-
munocompetent spleen cells containing CD4+ cells, it does
not necessarily indicate that resistance of conventional mice
to PCP is dependent on CD4+ cells. However, the finding
that conventional mice depleted of CD4+ cells develop PCP
strongly indicates that CD4+ cells are indeed required for
normal host resistance to PCP. This finding was recently
reported by Shellito et al. (7) during the writing ofthis manu-
script .
It was not determined whether the splenocytes infused
into the SCID mice were previously sensitized to PC. How-
ever, the serum of the donor BALB/c mice did contain anti-
PC IgG (results not shown), as did the serum ofreconstituted
SCID mice already at 4 d after reconstitution (data not shown).
Together, these two findings suggest that the donor mice
were previously exposed to and sensitized to PC antigens.
Although results of this investigation indicate CD4+ cells
play a critical role in resistance to PCP, whether they func-
tion as helper cells in the induction of an antibody response
to PC, or as contributors to cellular immunity to this or-
ganism, is not yet known. In the experiments described in
this study, B cells, as well as T cells, were transferred to re-
cipient SCID mice, and large numbers ofB cells were found
in lymphoid tissues after reconstitution. The fact that large
numbers of Ig+ cells were not found in the lungs of recon-
stituted SCID mice need not indicate that PC-specific anti-
bodies are not important in resolving PCP. On the contrary,
it has been shown that antigen deposition in the lungs does
not always cause antibody-secreting cells to accumulate (14,
15). The likelihood that an antibody response is in progress
is instead indicated by the accumulation of B cells in the TBLN
(15). In this regard, we found large numbers of Ig+ cells in
TBLN of reconstituted SCID mice resolving PCP.
The report by Furuta et al. (6), which showed that T cells
are necessary for resistance to PCP, does not rule out the pos-
sibility that humoral immunity plays a role in resistance to
PCP. These authors transferred T cells into nude mice that
already contained B cells, and by doing so, could have made
it possible for the recipient nude mice to mount a T cell-de-
pendent antibody response to PC. The knowledge that PC
is an extracellular parasite (16) and that antibodies greatly
augment phagocytosis and killing ofPC by macrophages (17)
also suggests a possible role for antibodies in resistance to
the organism. Nevertheless, cell-mediated immunity could
also play an essential role in resistance to PCP. Our observa-
tion that the lungs of reconstituted SCID mice contained
acquired lymphocytes, large numbers of macrophages, and
numerous giant cells is consistent with the interpretation that
these cells were acquired as part of a cell-mediated immune
response in the lungs. Indeed, it is possible that a T cell-medi-
ated response in and of itself could cause clearance of PC.
Alternatively, a T cell-mediated response couldserve to aug-
ment antibody-mediated defense mechanisms, possibly by ac-
tivating the microbicidal ability of phagocytes.
The finding that resistance of reconstituted SCID and con-
ventional mice to PCP can be eliminated by depleting them
of CD4+ T cells suggests that these mice and AIDS patients
may be susceptible to PCP for similar reasons. Therefore, both
models may be useful for analyzing the basis for suscepti-
bility ofthe immunocompromised host to PCP. Experiments
designed to determine whether CD4+ cells function in re-
sistance to PCP by mediating humoral responses, T cell-medi-
ated responses, or both are currently in progress in this labo-
ratory. Some ofthese experiments are best performed in SCID
mice because they lack functional B cells, as well as func-
tional T cells (8).
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